4XS.F : Summary for EXPRESS SCRIPTS HLDG - Yahoo Finance

U.S. Markets closed

Express Scripts Holding Company (4XS.F)


Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
59.93+0.54 (+0.91%)
At close: 3:14PM CEST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close59.39
Open59.85
Bid0.00 x 50000
Ask0.00 x 50000
Day's Range59.81 - 60.12
52 Week Range58.46 - 73.62
Volume408
Avg. Volume102
Market Cap36.29B
Beta0.98
PE Ratio (TTM)11.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
  • Forbesyesterday

    Regeneron's New Drug Price Could Disappoint Everyone. Here's Why That's A Good Thing

    Regeneron's billionaire chief executive Leonard Schleifer has said that the drug industry's pricing is "ridiculous." So when his own new drug, Dupixent for eczema, was approved, he took an unorthodox path to setting its $37,000-a-year list price.

  • Reuters5 days ago

    Judge dismisses two Express Scripts claims in Anthem drug pricing lawsuit

    A federal judge has dismissed two of the six counterclaims that pharmacy benefits manager Express Scripts Holding Co raised in health insurer's Anthem Inc's $15 billion lawsuit claiming it charged too much for drugs. In a decision made public on Friday, U.S. District Judge Edgardo Ramos in Manhattan dismissed Express Scripts' claim that Anthem breached an implied covenant of good faith and fair dealing, saying it duplicated a breach of contract claim. Anthem had sued Express Scripts last March, accusing it of excessive pricing and operational failures.

  • My 3 Worst-Performing Stocks -- and Why I Still Own Them
    Motley Fool7 days ago

    My 3 Worst-Performing Stocks -- and Why I Still Own Them

    Short-term pain with Molina Healthcare, Gilead Sciences, and Express Scripts stocks could still turn into long-term gains.